Kindbody introduced it had acquired Chicago-based surrogacy company Various Reproductive Assets, the most recent in a spate of offers by the hybrid fertility care and advantages firm this 12 months.
Kindbody stated the acquisition will convey surrogacy providers in-house. ARR’s staff will work within the firm’s KindEOS division, which focuses on egg and embryo donation.
This marks the corporate’s third acquisition up to now in 2022. In February, Kindbody stated it had entered into an settlement to purchase Vios Fertility Institute, a series of fertility clinics. It additionally added in-house genetic testing with the acquisition of Phosphorus Labs earlier this summer season.
“The trail to parenthood with gestational surrogacy is advanced, costly, and might final many months and even years,” Greg Poulos, president of Kindbody, stated in an announcement. “By bringing gestational surrogacy in-house and integrating it with Kindbody’s care-delivery mannequin, we have now the chance to dramatically enhance conception possibilities, decrease prices and assist our sufferers convey dwelling a wholesome child as quickly as doable. I’m delighted to welcome the ARR group to the Kindbody household and sit up for having them be a part of the KindEOS group.”
THE LARGER TREND
Kindbody introduced $62 million Sequence C funding a couple of 12 months in the past and $32 million Sequence B financing in 2020. The fertility startup stated its complete increase is $154 million. The corporate has additionally been increasing its brick-and-mortar clinic footprint this 12 months and launched a line of dwelling fertility hormone checks for ladies and men.
In the meantime, a rising variety of employers are providing fertility advantages to their staff. In keeping with a Mercer survey of employer-sponsored well being plans, solely 36% of corporations with 20,000 or extra staff provided in-vitro fertilization protection in 2015, in contrast with 42% in 2020.
One other startup within the house is fertility-benefits supervisor Carrot Fertility, which raised $75 million in Sequence C funding final 12 months. Direct-to-consumer virtual-care firm Ro has additionally been delving deeper into fertility care with the acquisition of Dadi, a male-fertility-testing and sperm-testing startup. It had additionally bought Fashionable Fertility in 2021. One other male-fertility startup, Legacy, scored $25 million in Might, and hybrid ladies’s well being supplier Tia not too long ago expanded into fertility testing, counseling and care planning.